110 related articles for article (PubMed ID: 17241428)
41. Inositol hexaphosphate and paclitaxel: symbiotic treatment of oral cavity squamous cell carcinoma.
Janus SC; Weurtz B; Ondrey FG
Laryngoscope; 2007 Aug; 117(8):1381-8. PubMed ID: 17607147
[TBL] [Abstract][Full Text] [Related]
42. Establishment of a cisplatin-resistant KB cell line and its characterization.
Hori Y; Kawamoto K; Yamazaki N; Kumazawa H; Yamashita T; Kumazawa T
Acta Otolaryngol Suppl; 1993; 500():142-8. PubMed ID: 8452014
[TBL] [Abstract][Full Text] [Related]
43. Quercetin inhibits proliferation and drug resistance in KB/VCR oral cancer cells and enhances its sensitivity to vincristine.
Yuan Z; Wang H; Hu Z; Huang Y; Yao F; Sun S; Wu B
Nutr Cancer; 2015; 67(1):126-36. PubMed ID: 25514492
[TBL] [Abstract][Full Text] [Related]
44. [Inhibition of the growth of hepatoma and hepatic metastasis by pingyangmycin conjugated with Fab' fragment of monoclonal antibody].
Liu X; Shang B; Liu X
Zhonghua Yi Xue Za Zhi; 2001 Feb; 81(4):201-4. PubMed ID: 11798873
[TBL] [Abstract][Full Text] [Related]
45. Tumor-specific cytotoxicity and type of cell death induced by gefitinib in oral squamous cell carcinoma cell lines.
Chu Q; Amano O; Kanda Y; Kunii S; Wang Q; Sakagami H
Anticancer Res; 2009 Dec; 29(12):5023-31. PubMed ID: 20044612
[TBL] [Abstract][Full Text] [Related]
46. [Mechanism of enhancement of bleomycin A5 antitumor activity by verapamil].
He NG; Zhang HQ; Song PG; Liu ZM; Xue SB
Yao Xue Xue Bao; 1991; 26(1):15-9. PubMed ID: 1716040
[TBL] [Abstract][Full Text] [Related]
47. [Effects of pingyangmycin on mucous membrane of respiratory tract and its prevention].
Chen F; Lin SZ; Gong ZP
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2003 Aug; 38(4):285-8. PubMed ID: 14743640
[TBL] [Abstract][Full Text] [Related]
48. [Experimental study of combined target treatments using PYM-BAC5 and 131I-BAC5 to nasopharyngeal carcinoma].
Liang ZP; Liu CZ; Cheng JY; Xiao XB; Zhang CQ; Liang CS
Ai Zheng; 2003 Aug; 22(8):831-5. PubMed ID: 12917029
[TBL] [Abstract][Full Text] [Related]
49. [In situ expression of transforming growth factor beta 1 in the process of induction chemotherapy for oral squamous cell carcinoma].
Tang W; Tian WD; Li SW; Tang YC
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Jan; 35(1):42-3, 90. PubMed ID: 14981811
[TBL] [Abstract][Full Text] [Related]
50. Enhancement of cisplatin induced apoptosis by suberoylanilide hydroxamic acid in human oral squamous cell carcinoma cell lines.
Shen J; Huang C; Jiang L; Gao F; Wang Z; Zhang Y; Bai J; Zhou H; Chen Q
Biochem Pharmacol; 2007 Jun; 73(12):1901-9. PubMed ID: 17445779
[TBL] [Abstract][Full Text] [Related]
51. [Combined injection of pingyangmycin & dexamethasone for the treatment of maxillofacial and cervical venous malformations].
Zhai J; Zhai XD
Zhonghua Zheng Xing Wai Ke Za Zhi; 2012 May; 28(3):168-71. PubMed ID: 22870701
[TBL] [Abstract][Full Text] [Related]
52. The mechanism of acacetin-induced apoptosis on oral squamous cell carcinoma.
Kim CD; Cha JD; Li S; Cha IH
Arch Oral Biol; 2015 Sep; 60(9):1283-98. PubMed ID: 26099663
[TBL] [Abstract][Full Text] [Related]
53. [Lymphatic targeting study of pingyangmycin-activated carbon nanoparticles treating oral cancer lymph node metastasis].
Sun ML; Xie WH; Wang CM; Wen YM
Hua Xi Kou Qiang Yi Xue Za Zhi; 2011 Jun; 29(3):253-6, 263. PubMed ID: 21776848
[TBL] [Abstract][Full Text] [Related]
54. Induction of cell death by combination treatment with cisplatin and 5-fluorouracil in a human oral squamous cell carcinoma cell line.
Okamura M; Kobayashi M; Suzuki F; Shimada J; Sakagami H
Anticancer Res; 2007; 27(5A):3331-7. PubMed ID: 17970078
[TBL] [Abstract][Full Text] [Related]
55. [The clinical application and evaluation of combined chemotherapy in comprehensive treatment for oral squamous cell carcinoma].
Liu S; Liao C; Wang D
Hua Xi Kou Qiang Yi Xue Za Zhi; 2003 Apr; 21(2):109-11. PubMed ID: 12838692
[TBL] [Abstract][Full Text] [Related]
56. [Expression of X-linked inhibitor of apoptosis protein in Tca8113 cell and its relationship to chemoresistance].
Wang JF; Zhang ZM; Wang CK; Nie DB; Gao WX
Hua Xi Kou Qiang Yi Xue Za Zhi; 2010 Feb; 28(1):92-4. PubMed ID: 20337086
[TBL] [Abstract][Full Text] [Related]
57. Study of a pingyangmycin delivery system: Zein/Zein-SAIB in situ gels.
Gao Z; Ding P; Zhang L; Shi J; Yuan S; Wei J; Chen D
Int J Pharm; 2007 Jan; 328(1):57-64. PubMed ID: 16939703
[TBL] [Abstract][Full Text] [Related]
58. [Apoptosis of human carcinoma of mouth floor KB cells and multidrug resistant KBv200 cells induced by azide methyl anthraquinone derivative].
Ding Y; He LR; Cao KJ; Lu Y; Gu LQ; Fu LW
Yao Xue Xue Bao; 2005 Jan; 40(1):22-6. PubMed ID: 15881321
[TBL] [Abstract][Full Text] [Related]
59. Pingyangmycin as a 99mTc carrier in tumor localization.
Huang T; Zhang Y; Wang J; Huang J; Liu D; Mong S
Nucl Med Biol; 1995 May; 22(4):537-42. PubMed ID: 7550032
[TBL] [Abstract][Full Text] [Related]
60. Re-evaluation of tumor-specific cytotoxicity of mitomycin C, bleomycin and peplomycin.
Sasaki M; Okamura M; Ideo A; Shimada J; Suzuki F; Ishihara M; Kikuchi H; Kanda Y; Kunii S; Sakagami H
Anticancer Res; 2006; 26(5A):3373-80. PubMed ID: 17094455
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
